FDA Will Announce Rare Incidence Of Guillain-Barre Linked To Johnson & Johnson Vaccine The United States Centers for Disease Control and Prevention issued a statement regarding the Johnson & Johnson/Janssen Covid-19 vaccine, sharing that approximately 100 individuals suffered from a rare neurologic disorder called Guillain-Barre syndrome after receiving this vaccine.